Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-001-8 | CAS number: 50-00-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- The determination of exogenous formaldehyde in blood of rats during and after inhalation exposure
- Author:
- Kleinnijenhuis A.J., Staal Y.C.M., Duistermaat E., Engel R., Woutersen R.A.
- Year:
- 2 013
- Bibliographic source:
- Food and Chemical Toxicology 52 (2013) 105–112
Materials and methods
- Objective of study:
- absorption
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: OECD Guideline 403 (2009)
- Principles of method if other than guideline:
- Blood concentrations of FA during and after single 6-h exposure by inhalation were determined. In order to differentiate between exogenous and endogenous FA the rats were exposed to stable isotope (13C) labeled FA by inhalation. During and after exposure of the rats to 13C–FA their blood was analyzed to determine the ratio between labeled and natural FA in blood and the total blood concentration of FA.
- GLP compliance:
- yes
Test material
- Reference substance name:
- Formaldehyde
- EC Number:
- 200-001-8
- EC Name:
- Formaldehyde
- Cas Number:
- 50-00-0
- Molecular formula:
- CH2O
- IUPAC Name:
- formaldehyde
- Details on test material:
- - Name of test material (as cited in study report): formaldehyde
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): formaldehyde–13C solution
- Composition of test material, percentage of components: 19.3% in aqueous solution (99.4 atom% 13C)
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories
- Age at study initiation: about twelve weeks old
- Diet: The animals received a cereal-based (closed formula) rodent diet (Rat & Mouse No. 3 Breeding Diet, RM3; pelleted) from a commercial supplier (SDS Special Diets Services, Witham, England), ad libitum
- Water: ad libitum
Administration / exposure
- Route of administration:
- inhalation: vapour
- Vehicle:
- other: pressurized air
- Details on exposure:
- TYPE OF INHALATION EXPOSURE: nose only
GENERATION OF TEST ATMOSPHERE / CHAMPER DESCRIPTION
To generate the test atmosphere, a volume of test substance diluted in water (0.1276% m/m), controlled by a motordriven syringe pump (WPI Type SP220i, World Precision Instruments, Sarasota FL, USA), was allowed to evaporate in a heated glass evaporator and mixed with a mass flow controlled (Bronkhorst Hi Tec, Ruurlo, The Netherlands) amount of pressurized air. The resulting test atmosphere was led to the noses of the animals. During the generation of the test atmosphere, the readings of the mass flow controller were recorded at regular intervals (approximately each 30 min). The airflow through the exposure chamber measured with a mass flow controller was 15 L/min. The animals were placed in the exposure unit after stabilization of the test atmosphere. The actual FA air concentration was determined by leading test atmosphere through 2,4-DNPH-cartridges and subsequent HPLC–UV analysis, as is described in more detail below.
The animals were exposed to the test atmosphere in a nose-only inhalation chamber, a modification of the design of the chamber manufactured by ADG Developments Ltd., Codicote, Hitchin, Herts SG4 8UB, United Kingdom. The animals were secured in plastic animal holders (Battelle), connected via ports to the inhalation unit. The total air flow through the unit was monitored about every 30 min and was at least 1 L/min for each rat. The air entering the unit was controlled at a temperature of 20–24°C and a relative humidity between 30 and 70%.
FA quantification in air:
The test set for the validation of the quantification method of FA in air contained 5 2,4-DNPH-cartridges fortified at approximately 6 lg FA with a formaldehyde solution in milliQ water, 5 samples fortified at approximately 18 lg FA and 2 unfortified control samples. Air (ambient temperature and relative humidity, 1 L/min) was led through the 2,4-DNPH-cartridges (Waters XpoSure Aldehyde 2,4-DNPH cartridges, lot number 002830309E) for approximately 10 min. - Duration and frequency of treatment / exposure:
- 6 hr and 3 min. One animal was found dead during exposure and this animal was replaced with another animal, which was exposed for 5 h.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 10 ppm
- Dose / conc.:
- 9.65 ppm
- Remarks:
- Analytical concentration
- No. of animals per sex per dose / concentration:
- 10
- Details on dosing and sampling:
- - The animals were observed for clinical signs just before exposure and five times during exposure (about once per hour, starting about 1 h after initiation of treatment).
- Blood samples were taken from each rat prior to exposure (t = 0), at t = 3 h during exposure, at t = 6 h (end of exposure), at t = 6 h and 10 min and at t = 6 h and 30 min (10 and 30 min after exposure).
- FA was determined in blood using High Performance Liquid Chromatography–Tandem Mass Spectrometry (HPLC–MS/MS). The test set for the validation of the quantification method of analysis of FA in blood contained 6 unfortified control samples (from 6 different rats => variation between rats), 5 samples fortified at 2 mg/L and 5 samples fortified at 6 mg/L (in total two and four times the expected endogenous FA concentration of approximately 2 mg/L). The endogenous FA blood concentration was subtracted from the blood concentration found in fortified samples to calculate the recovery. Additionally, unfortified blood samples from 1 rat were prepared and analyzed in fivefold to determine the repeatability in FA blood concentration analysis (analytical variation). Fortified blood samples were prepared using non-derivatized natural FA, which is chemically identical to 13C–FA. Because we determined the fraction of exogenous formaldehyde in blood using the isotopic distribution, the natural formaldehyde signal, for which the isotopic distribution is known, acts as an internal standard for the exogenous formaldehyde signal.
Results and discussion
Metabolite characterisation studies
- Metabolites identified:
- not measured
- Details on metabolites:
- - The observed Relative Standard Deviations (RSDs) in FA concentration determined in unfortified blood control samples and the observed RSDs in the recoveries for blood samples fortified at 2 and 6 mg FA/L were lower than 10%. These results demonstrate that FA concentrations can be determined with good repeatability in (un)fortified blood and that fortified FA is recovered from blood under the experimental conditions.
- The FA blood concentrations determined were in the 1.9–5.4 mg/L range.
- The FA concentration in blood did not increase during exposure.
- The applied method would have allowed the detection of exogenous 13C–FA in blood at a concentration approximately 1.5% of the endogenous FA blood concentration. The overall conclusion is that the inhalation of 13C–FA at 9.65 ppm (target concentration 10 ppm) had no effect on the FA concentration in blood. Exogenous 13C–FA was not detected in the blood of rats exposed to 9.65 ppm FA during or after (up to 30 min) inhalation for 6 h and 3 min using the experimental conditions of this study.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.